• Share

EVIS X1 — Our Most Advanced Endoscopy System

EVIS X1 represents a range of innovative, easy-to-use technologies that aim to revolutionise the way gastrointestinal disorders can be detected, characterised and treated.

We want to support every endoscopist.
In every procedure. Every day.

Contact

TXI:
The New White Light

TXI (Texture and Colour Enhancement Imaging) aims to enhance the visibility of suspicious tissue by improving the color, structure and brightness of the endoscopic image.

Before
After

Designed to Improve Detection Rates

By supporting better visibility of potential lesions (e.g. inflammations, flat or depressed lesions), TXI aims to contribute to higher detection rates.

Texture and Colour Enhancement Imaging

Learn more about the technology behind TXI and its benefits.

ENDO-AID CADe: The [AI]d in Endoscopy

ENDO-AID CADe is a computer-aided detection application that uses AI to suggest the potential presence of lesions such as colonic polyps, malignant neoplasms and adenomas.

Learn more about ENDO-AID CADe

Aims to Increase the ADR

By supporting the identification of lesions, ENDO-AID CADe aims to increase the adenoma detection rate.*

* Compared to WLI without CADe.

Read more in the study

Computer-Aided Detection

Learn more about the technology behind ENDO-AID CADe and its benefits.

NBI: The Power of Accurate Diagnosis

NBI (Narrow Band Imaging) is a proven optical technology that allows for a reliable optical diagnosis of all major indications in the gastrointestinal tract.2

Before
After

NBI: Proven Results

NBI enables the practical deployment of several strategies for efficient lesion management. These include:

  • Targeted biopsies in the upper gastrointestinal tract.2,3
  • Easier decision-making for suitable endoscopic resection techniques.4,3
  • Potentially avoiding histological assessment of low-risk lesions (e.g. diminutive rectosigmoid polyps under the resect and discard paradigm).5-7

Narrow Band Imaging

Learn more about the technology behind NBI and its benefits.

RDI: Designed to aid in Endoscopic Therapy

RDI (Red Dichromatic Imaging) is designed to enhance the visibility of deep blood vessels and bleeding sources.

Visibility of Deep Blood Vessels and Bleeding Points

Easier identification of bleeding points. Visualisation of deep blood vessels indicates areas of risk.

Red Dichromatic Imaging

Learn more about the technology behind RDI and its benefits.

EDOF:
The Phenomenon of Full Focus

EDOF (Extended Depth of Field) allows precise endoscopic observations through continuous broad focus and seamless magnification. The established Dual Focus function provides high magnification.

Continuous Sharp Images for
Improved Visibility

The continuously sharp image was developed to reduce the necessity for focal adjustments. This improved visibility helps to make endoscopy more convenient and may even contribute to easier identification and a more confident diagnosis of abnormalities.

Extended Depth
of Field

Learn more about the technology behind EDOF and its benefits.

A Unified Platform with Broad Compatibility

One dedicated platform: EVIS X1 merges the two worlds of EVIS EXERA III and EVIS LUCERA ELITE into one —resulting in a vastly extended portfolio of compatible endoscopes.

Ready for the Future: Artificial Intelligence (AI)

In AI, we recognise the power of elevating endoscopic imaging to greater levels. Considering ENDO-AID CADe as a first step, we are planning additional AI-powered applications for image detection and characterisation.

Additional Features and Technologies

EVIS X1 provides diagnostic and therapeutic innovation alongside proven technologies to improve endoscopic procedures and endoscope handling.

5 LED Spectrum Technology

The EVIS X1 Video System Center contains five LEDs that are combined to produce different observation modes. It includes an Olympus tailored amber LED enabling the visualisation capabilities of the RDI mode. LEDs have a longer life span than other light sources while consuming less energy.

BAI-MAC — Improved Image Quality

BAI-MAC (Brightness Adjustment Imaging with MAintenance of Contrast) is an image processing technique to improve the brightness levels in dark areas of the endoscopic image, whilst maintaining the brightness of lighter areas to increase the distance view.

ErgoGrip — Improved Control Section

The lightweight and more ergonomic ErgoGrip is designed to increase user comfort and scope handling. It accommodates users with smaller hands with improved accessibility to the angulation controls and remote switches.

Touch Panel

The EVIS X1 Video System Centre is operated from a touch panel on the front of the unit, allowing the user to initiate all procedures and settings and control the image data from one device.

Responsive Insertion Technology (RIT)

Combines PB (Passive Bending), HFT (High Force Transmission) and variable stiffness for ease of insertion and operator control.

ScopeGuide

Provides a real-time, three-dimensional view of the shape of the colonoscope during a procedure.

Learn more about ScopeGuide >

Dual Focus — Two-Stage Optical Lens Technology

Allows switching from normal focus to near focus mode with a single button, so physicians can conduct close examination of mucosal tissue and capillary networks.

Pre-Freeze Function — Updated Algorithm

Pre-freeze analyses previous images to obtain a clear visual record of the procedure (this is an updated algorithm compared to the EVIS EXERA III / EVIS LUCERA ELITE systems).

Water Jet

Enabled by the auxiliary water channel, the Water Jet function supports observations and endoscopic treatment by removing mucus and other residues in the investigated areas.

Narrow Band Imaging (NBI)

NBI significantly outperforms other optical technologies in detecting cancer and characterising suspicious mucosal areas.

Learn more about NBI >

Sources related to NBI:

1 Olympus Proven; available at https://www.olympus-proven.com.au/less-biopsies/.
2 Olympus Proven; available at https://www.olympus-proven.com.au/increased-adr/.
3 Thosani et al. Gastrointest Endosc 2016 Apr; 83(4): 684-698.e7.
4 Pimentel-Nunes et al. Endoscopy 2019; 51: 365-388.
5 Yao et al. New Challenges in Gastrointestinal Endoscopy 2008, pp. 169-176.
6 Dayyeh et al. Gastrointest Endosc. 2015 Mar; 81(3): 502.e1-502.e16.
7 Kaminski et al. Endoscopy. 2014 May; 46(5): 435-49.
8 National Institute for Health and Care Excellence (NICE) 2017; Diagnostics guidance [DG28]; available at https://www.nice.org.uk/guidance/dg28.